Senior citizens who received a second booster of the Pfizer-BioNTech COVID-19 vaccination had a 78% lower mortality rate from the disease than those who got one only, a study from Israel showed on Sunday.The country’s largest healthcare provider, Clalit Health Services,…

Read Full Article (External Site)